Chapter 1065 Take the Opportunity to Make a Lot of Money

The surge of Pfizer and Ito has made other pharmaceutical companies see another way to make money.

As long as it has a relationship with Xingchen Pharmaceutical, its own stock price can go up.

Companies that can win the exclusive agency rights in one region or even multiple regions are basically listed companies.

Companies that have obtained exclusive agency rights have disclosed the news that their companies have obtained exclusive agency rights. As expected, their stock prices have risen.

Because of the rise of many pharmaceutical companies, it has even led to a surge in the global pharmaceutical industry.

Since the last time the pharmaceutical industry was exposed to various violations and other operations, which led to the decline of the overall pharmaceutical industry, this is the fastest time for the overall pharmaceutical industry to rise.

Some companies are even taking this opportunity to make another great mark.

Some people are sighing that if Xingchen Pharmaceutical is not a private company, only relying on today's auction can make Xingchen Pharmaceutical rise to sky-high prices.

It is a pity that none of the subsidiaries of Xingchen Group, including Xingchen Group, are listed.

Other companies go public for financing, to make money, and to make the company's products better.

However, Xingchen Group does not need financing at all, and he himself has a large amount of cash flow.

Even the bank asked the Star Group to lend to their company.

In fact, many large enterprises, especially those with particularly rich cash flow, do not borrow from banks, but instead let their money be loaned to others, and money begets money.

For example, the enterprises of Alima and Xiao Ma are like this.

Alima can be said to be the man who made major changes in Huaxia's payment system and forced the banking system to make adjustments.

The sharp rise in the pharmaceutical industry can actually be seen for a long time.

The last cyber incident caused the entire pharmaceutical industry to drop by nearly half, which is not normal.

After all, there are very few companies that have scandals. Most companies do not have this problem, and it cannot be said that there is no such problem, at least not exposed to the eyes of the general public.

This has led to an excess of decline. Taking advantage of this opportunity, many of the pharmaceutical companies involved have risen.

Ordinary people can see this opportunity, how can some oligarchs not see it.

An investment company has also been established in the Xingchen Group. As I said before, the cash flow of the Xingchen Group is too much.

Money doesn't make money, you can only make money by investing it.

Putting money in the bank or in various financial products for interest is indeed a more suitable method for ordinary people.

After all, ordinary people have limited investment channels, and financial management such as banks has relatively low relative risks.

It is naturally impossible for Xingchen Group to do this. Investing in some products is far higher than putting it in a bank. This is why banks sometimes ask Xingchen Group for deposits and loans.

The surge in the pharmaceutical industry this time is all under the control of Xingchen Group. How could Xingchen Investment miss this opportunity?

Whether it's the last scandal or this auction of exclusive agency rights for cancer generic drugs, the Star Group has made a lot of money in it.

Xingchen Investment spent nearly 50 billion US dollars this time, which doubled in less than a month.

The speed of making money is absolutely terrifying.

In general investment, 20% a year is considered a very good investment.

This time, in less than a month, the rate of return was as high as 100%.

Just looking at the rate of return, there are many investment projects that can achieve this level, but if you look at the scale, you will be intimidated.

It's not that Xingchen Investment doesn't want to make more money, who doesn't want to make more money, Xingchen Group has more money, but there are also many projects launched, and it needs to spend money everywhere.

Is it unbearable?

Of course not, the main reason is that this plate is too small, and the fluctuations caused by 50 billion US dollars are too great.

Fifty billion is not a small number. Even if it is spread among a large number of accounts, it is still a huge number.

This is the reason why Xingchen Pharmaceutical finally spent 50 billion US dollars.

Because Xingchen Group is not listed, except Liu Mingyu, no one knows how much Xingchen Group has.

Even Liu Mingyu himself can only know the assets he currently owns, because his assets are increasing every moment.

Liu Mingyu once read a joke on the Internet. It was about Bill Gates, the richest man in the world. If Bill Gates saw a hundred dollars on the street, he would not bend over to pick it up, because he would bend over to pick up the money. In the time he has created, the value he has created has far exceeded one hundred dollars.

This is just a joke on the internet.

Later, a new joke came out. I went up to one million in minutes, and I didn't have time to talk to you here.

Although these two are jokes, Liu Mingyu's state at the moment is even more exaggerated than what is described in the jokes.

From the time he founded the Xingchen Group to the present, the market value has long been increased by an unknown number of times. According to such a ratio, it definitely exceeds the amount mentioned in the two paragraphs.

The effects of the generic cancer drug continue and will not subside any time soon.

The news that Hou Yaolin was selected for the 2021 Nobel Prize in Medicine has been republished again.

If the 2020 Nobel Prize had not been announced in October, Hou Yaolin would likely have won it directly.

Now only the 2021 Nobel Prize in Medicine can be scheduled.

There have been nominations before, but because the universal drug for cancer treatment has not been officially used on a large scale, the Nobel Prize selection committee remained cautious and did not immediately join the nomination.

Every nomination has to be carefully and carefully. Before the Nobel Prize is awarded to someone, it will have very serious consequences.

This isn't something without a criminal record.

In the history of the Nobel Prize, there have been many wrong and even disastrous choices.

The most noteworthy here is the 1949 Nobel Prize in Physiology and Medicine, awarded to Walter Hess and Anthony Moniz for "discovering the therapeutic value of lobotomies in certain psychiatric disorders".

They proposed prefrontal lobotomies to treat schizophrenia, whereby neurosurgeons in the United States perform prefrontal lobectomies on thousands of patients each year, some with horrific negative effects, many The patient loses sense of direction or ability to act, becomes a vegetative state, or even dies.

This is definitely a very serious accident.

There are many similar situations.

As an award that is the highest honor in the scientific community, and there is a lesson from the past, no amount of caution can be overemphasized.